Refine Search
(270)
(517)
(849)
(1780)

NEW PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2018 Edition

  • $4,995
  • September 2018
Add to Basket Quick View Add to Saved List

The motivation for pharma companies outsourcing their manufacturing is often to do with lacking expertise, equipment, or cost reduction (especially for small to mid-sized CMOs) in development of their product’s API or dose. For clinical dose ma...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Morocco

  • $1,995
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Morocco”. The report is an essential source of information and analysis on the healthcare, regulat...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Nigeria

  • $1,995
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Nigeria”. The report is an essential source of information and analysis on the healthcare, regulat...

NEW Digital Landscape: Rheumatoid Arthritis

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Rheumatoid Arthritis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe rheumatoid arthritis (RA).

NEW Digital Landscape: Inflammatory Bowel Disease

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).

NEW Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $7,995
  • September 2018
Add to Basket Quick View Add to Saved List

Market access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more stringent scientific and value assessments and economic pressures on national budgets and health systems. Although, 5EU...

NEW Digital Transformations and Emerging Technologies in the Healthcare Industry – H2 2018

  • $1,495
  • September 2018
Add to Basket Quick View Add to Saved List

Digital transformation generally refers to the utilization of emerging technologies to solve traditional problems. Instead of simply supporting traditional methods, digital transformation has the ability to lead to innovation in a business sett...

NEW Stem Cells in Neurology

  • $7,995
  • September 2018
Add to Basket Quick View Add to Saved List

Stem cells in neurology is an evolving field. The current pipeline of products feature different types of stem cells and these therapies have the potential to target a range of neurological diseases. However, there are challenges associated wit...

NEW Digital Landscape: Breast Cancer

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Breast Cancer report analyzes digital activities undertaken by pharma in support of therapies for breast cancer.

NEW Digital Landscape: Ankylosing Spondylitis

  • $6,000
  • September 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Ankylosing Spondylitis report analyzes digital activities undertaken by pharma in support of therapies for active Ankylosing Spondylitis (AS)

NEW PARP Inhibitors in Oncology

  • $7,995
  • September 2018
Add to Basket Quick View Add to Saved List

Since hitting the market in 2015, drugs that target poly (ADP-ribose) polymerase (PARP) have transformed the clinical management of cancers harboring BRCA-mutations. As more PARP inhibitors have been commercialized, drug developers are turning ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Finland

  • $1,995
  • August 2018
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Finland”. The report is an essential source of information and analysis on the healthcare, regulat...

Digital Landscape: Multiple Sclerosis

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Multiple Sclerosis report analyzes digital activities undertaken by Pharma in support of disease-modifying therapies for Multiple Sclerosis (MS).

Digital Landscape: Type 2 Diabetes

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Type 2 Diabetes report analyzes digital activities undertaken by Pharma in support of therapies for Type 2 Diabetes (T2D).

Digital Landscape: Psoriasis

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Psoriasis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe psoriasis (PsO).

Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks